Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
10,288,626
Publication Date
5-14-2019
Abstract
Disclosed herein are methods for detecting Pgrmc 1 in bodily fluids, e.g., blood, plasma and serum, wherein detection of Pgrmcl is a biomarker for the presence of cancer, e.g., lung cancer or head or neck cancer. Pgrmc 1 levels in bodily fluids may be used to predict patient prognosis, e.g., survival and response to therapy.
Assignees
University of Kentucky Research Foundation, Lexington, KY, (US)
Application Number
14/028,224
Filing Date
09/16/2013
Recommended Citation
Craven, Rolf Joseph, "Secreted Tumor-Associated Cytochrome as a Blood-Based Biomarker for Cancer" (2019). Pharmacology and Nutritional Sciences Faculty Patents. 53.
https://uknowledge.uky.edu/pharmacol_patents/53
